Filter News
Area of Research
News Topics
- (-) Biomedical (17)
- (-) Buildings (15)
- (-) Molten Salt (3)
- 3-D Printing/Advanced Manufacturing (45)
- Advanced Reactors (10)
- Artificial Intelligence (33)
- Big Data (7)
- Bioenergy (23)
- Biology (22)
- Biotechnology (8)
- Chemical Sciences (32)
- Clean Water (2)
- Climate Change (22)
- Composites (11)
- Computer Science (60)
- Coronavirus (17)
- Critical Materials (11)
- Cybersecurity (17)
- Decarbonization (20)
- Education (3)
- Element Discovery (1)
- Energy Storage (43)
- Environment (36)
- Exascale Computing (10)
- Fossil Energy (1)
- Frontier (15)
- Fusion (16)
- Grid (15)
- High-Performance Computing (30)
- Isotopes (18)
- ITER (2)
- Machine Learning (13)
- Materials (59)
- Materials Science (52)
- Mercury (2)
- Microelectronics (1)
- Microscopy (16)
- Nanotechnology (26)
- National Security (18)
- Net Zero (3)
- Neutron Science (51)
- Nuclear Energy (27)
- Partnerships (29)
- Physics (24)
- Polymers (12)
- Quantum Computing (10)
- Quantum Science (27)
- Renewable Energy (1)
- Security (11)
- Simulation (9)
- Space Exploration (3)
- Statistics (1)
- Summit (21)
- Sustainable Energy (30)
- Transformational Challenge Reactor (4)
- Transportation (25)
Media Contacts
Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.